OLMA Earnings

Quarterly EPS
$-0.54
Q2 2024
$-0.60
Q3 2024
$-0.51
Q4 2024
$-0.36
Q1 2025
$-0.51
Q2 2025
$-0.49
Q3 2025
$-0.50
Q4 2025
$-0.52
Q1 2026
Latest RevenueN/A
Latest Net Income-53089000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026-$0.520-53089000-44.4%
Q4 2025-$0.500-46061000+2.0%
Q3 2025-$0.490-42217000+18.3%
Q2 2025-$0.510-43784000+5.6%
Q1 2025-$0.360-30389000+35.7%
Q4 2024-$0.510-33567000-4.1%
Q3 2024-$0.600-34555000-25.0%
Q2 2024-$0.540-30382000-10.2%
Q1 2024-$0.560-30970000
Q4 2023-$0.490-26772000
Q3 2023-$0.480-21502000
Q2 2023-$0.490-20095000
Olema Pharmaceuticals (OLMA) — Earnings